Hasan Tuncer, Ph.D.

Product Manager | AI & Robotics

📍 United States🔄 Updated October 2026💼 1 investments📅 10 years investing🗓 Last invested Jun 2016
Angel investor🌍 United States
1
Total investments
1
Early stage
0
Mid stage
0
Late stage
10y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Jun 2016
Transforming eye care through groundbreaking monitoring and treatment technologies. Smartlens is developing novel solutions for managing glaucoma and other anterior segment eye diseases. We are transforming traditional eye care into personalized, proactive disease management through our technologies addressing unmet needs in eye care since the 1950s. Our comprehensive platform combines: • Breakthrough, electronics-free contact lens for remote IOP monitoring - addressing a primary risk factor for glaucoma, the leading cause of irreversible blindness • Smart drug delivery platform that optimizes treatment timing and patient compliance • Advanced AI-powered imaging platform serving as a smart slit lamp for remote disease management Protected by patents in over 40 countries and backed by prominent VC firms and Stanford University, our solutions have demonstrated strong clinical results with commercialization planned for 2025. Recognized by Nature Medicine, Fortune, and BBC, Smartlens received the "Outstanding Innovation in Medical Technology and Life Sciences" award at the 2021 High-Tech Awards. Smartlens is committed to building a world where eye diseases no longer compromise quality of life, ensuring better outcomes for patients globally.
Experience · 2 entries
All (2)
Investments (1)
2016
Angel Investor
Jun 2016
Transforming eye care through groundbreaking monitoring and treatment technologies. Smartlens is developing novel solutions for managing glaucoma and other anterior segment eye diseases. We are transforming traditional eye care into personalized, proactive disease management through our technologies addressing unmet needs in eye care since the 1950s. Our comprehensive platform combines: • Breakthrough, electronics-free contact lens for remote IOP monitoring - addressing a primary risk factor for glaucoma, the leading cause of irreversible blindness • Smart drug delivery platform that optimizes treatment timing and patient compliance • Advanced AI-powered imaging platform serving as a smart slit lamp for remote disease management Protected by patents in over 40 countries and backed by prominent VC firms and Stanford University, our solutions have demonstrated strong clinical results with commercialization planned for 2025. Recognized by Nature Medicine, Fortune, and BBC, Smartlens received the "Outstanding Innovation in Medical Technology and Life Sciences" award at the 2021 High-Tech Awards. Smartlens is committed to building a world where eye diseases no longer compromise quality of life, ensuring better outcomes for patients globally.
2006
Student Partner
Sep 2006
Every company has a mission. Whats ours? To empower every person and every organization to achieve more. We believe technology can and should be a force for good and that meaningful innovation contributes to a brighter world in the future and today. Our culture doesn’t just encourage curiosity; it embraces it. Each day we make progress together by showing up as our authentic selves. We show up with a learn-it-all mentality. We show up cheering on others, knowing their success doesnt diminish our own. We show up every day open to learning our own biases, changing our behavior, and inviting in differences. Because impact matters. Microsoft operates in 190 countries and is made up of approximately 228,000 passionate employees worldwide.